Aesther Healthcare Acquisition Corp. Announces Separate Trading of its Class A Common Stock and Warrants to Commence on November 5, 2021
Aesther Healthcare Acquisition Corp. (Nasdaq: AEHAU) announced that starting November 5, 2021, holders of its initial public offering units may separately trade shares of Class A common stock and redeemable warrants. The Class A common stock will trade under the symbol AEHA and the warrants under AEHAW. The company will not issue fractional warrants and only whole warrants will trade. The units will continue to trade under AEHAU. This announcement follows a registration statement effective since September 14, 2021.
- Holders can separately trade shares and warrants, enhancing liquidity.
- Potential for strategic focus on pharmaceutical and medical device sectors.
- None.
NEW YORK, NY, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp. (Nasdaq: AEHAU) (the “Company”) today announced that, commencing November 5, 2021, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock and redeemable warrants included in the units.
No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The shares of Class A common stock and redeemable warrants that are separated will trade on the Nasdaq Capital Market under the symbols “AEHA” and “AEHAW,” respectively. Those units not separated will continue to trade on the Nasdaq Capital Market under the symbol “AHEAU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into shares of Class A common stock and warrants.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (the “SEC”) on September 14, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Aesther Acquisition Corp.
Aesther Healthcare Acquisition Corp. is a blank-check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on the pharmaceutical and medical device sectors.
Forward Looking-Statements
This press release contains statements that constitute “forward-looking statements,” including with respect to the search for an initial business combination. No assurance can be given that the proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Aesther Healthcare Acquisition Corp.
515 Madison Ave
Suite 8078
New York, NY 10022
Attn: Suren Ajjarapu
Chairman & CEO
suren@aestherhealthcarespac.com
(646) 908-2658
FAQ
When can holders of Aesther Healthcare Acquisition Corp. units trade their shares?
What symbols will Aesther Healthcare Acquisition Corp. shares and warrants trade under?
Will fractional warrants be issued by Aesther Healthcare Acquisition Corp.?
